Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Doungdean Tummanatsakun

Doungdean Tummanatsakun

Khon Kaen University Thailand

Kuo-Wang Tsai

Kuo-Wang Tsai

Kaohsiung Veterans General Hospital Taiwan

Chiung-Fang Chang

Chiung-Fang Chang

Far Eastern Memorial Hospital Taiwan

Han-Heom Na

Han-Heom Na

Kangwon National University South Korea

Jaecheong Lim

Jaecheong Lim

Korea Atomic Energy Research Institute South Korea

Darya Tsvirkun

Darya Tsvirkun

The Hebrew University of Jerusalem Israel

Surangkana Sanmai

Surangkana Sanmai

Khon Kaen University Thailand

Leung KN

Leung KN

The Chinese University of Hong Kong China

Global Cancer 2017

Sessions/Tracks

Conferenceseries LLC invites all the participants from all over the world to attend ‘Global Summit on Oncology & Cancer May 25-27, 2017 Osaka, Japan which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Global Cancer 2017 is a platform to discuss and learn about Cause of the cancer its Prevention, Diagnosis, and Treatment diseases of the Organ-related Cancers and its innovative techniques. This Global Cancer Conference will have three days of discussions on methods and strategies related to management, quality improvement of Cancer as well as to explore the new ideas and concepts on global scale and the topics include lung cancer, breast cancer, bone cancer,  blood cancer, cervical cancer, colon-rectum cancer, prostate cancer, thyroid cancer

Track 1: Oncology

Oncology is the study of cancer. An oncologist is a doctor who treats cancer. Usually, an oncologist manages a person’s care and treatment once he or she is diagnosed with cancer. A medical oncologist treats cancer using chemotherapy or other medications, such as targeted therapy. A surgical oncologist removes the tumor and nearby tissue during an operation. He or she also performs certain types of biopsies. A radiation oncologist treats cancer using radiation therapy. Oncologists may divide on the basis of the type of treatment provided to treat the cancer. Molecular oncology is the study of chemistry of cancer and tumor cell at its molecular cell. Surgical oncology is the branch of oncology which deals with the surgery applied to oncology. Gynaecologic oncology is focuses on different cancers of the female reproductive system.

Recommended Conferences:

16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE: Global Summit on Oncology & Cancer, May 25-27, 2017  Osaka, Japan: International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE: 9th International Cancer Biomarkers Conference, August 07-09, 2017  Osaka, Japan: 15th World Congress on Cancer Therapy December 05-07, 2016 Philadelphia, Pennsylvania, USA: 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA: Asia Pacific Breast Cancer Summit 17-19 Feb 2017, Hong Kong: 4th Asia Pacific Gastroenterology Cancer Summit , April 28-30, 2017 Singapore: ELCC 2017 European Lung Cancer Conference, May 05- 08 2017, Switzerland: IMPAKT 2017 Breast Cancer Conference 04 - 06 May 2017, Brussels, Belgium European Lung Cancer Conference, May 5-8, 2017, Switzerland;  2nd  Paediatric Oncology Conference , June 22-23, 2017 Philadelphia, USA; Paediatric Neuro-Oncology, Feb 13 2017 London, United Kingdom; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy

Related Cancer Conferences | Oncology Conferences | Cancer Science Conferences

Track 2: Cancer Cell Biology

Cancers are a large family of diseases that involve abnormal cell growth with the potential to invade or spread to other parts of the body. Cancer cells are those cells whose cell division and growth is unregulated. When the natural killer cells fail to recognize them, they start malignant. When cancer cells start spread from one part to another it is called metastasis. Tumor cell starts its growth in tumor microenvironment which included blood cell, immune cells, fibroblasts, lymphocytes etc. Symptoms of different cancers are depending upon the location of tumor. Cancer stem cells are stem cells which have the ability to give rise all type of cancer cells.

Recommended Conferences:

International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany: 19th World Cancer Conference, Nov 21-23, 2017 London, UK: 11th International Conference on Leukaemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain: Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France: 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2017 Atlanta, Georgia, USA: 2nd International Congress on Gynaecologic Oncology, and Contemporary Issues in Women Cancers Sep 5-6, 2017 London, UK: International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA: Paediatric Neuro-Oncology, Feb 13 2017 London, United Kingdom; Paediatric Academic Cancer Society Conference, May 6–9, 2017, California, USA, Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE: European Cancer Congress 27-30 January 2017, Amsterdam: 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 34th Annual Miami Breast Cancer Conference March 9-12, 2017 Miami Beach, FL: BIT's 10th Annual World Cancer Congress 19-21, May 2017, Barcelona, Spain: Iaslc/Esmo European Lung Cancer Conference May 5 - 8 2017, Geneva, Switzerland.

Related Cancer Conferences | Oncology Conferences | Cancer Science Conferences

Track 3: Cancer Epidemiology

Epidemiology of cancer is the study of the factors that affecting cancer. The study of epidemiology of cancer uses epidemiological methods to find the cause and to identify of cancer with the developed improved treatments. The leading risk factors are tobacco smoking, which cause lung cancer, mouth, and throat cancer; drinking alcohol, which cause oral, breast, Oesophageal cancer liver and other cancers; physical inactivity, a diet low in fruit and vegetables which can cause the risk of risk of colon, breast, and possibly other cancers.

Recommended Conferences:

Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK: 14th Annual Translational Medicine and Oncologists Conference Meet November 28-30, 2016 San Francisco, USA: 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain: 3rd World Gynaecologic Oncology Congress, July 20-21, 2017 Chicago, Illinois, USA: 19th Euro Congress on Cancer Science and Therapy, July 20-22, 2017 Lisbon, Portugal: World Congress on Preventive oncology July 20-21, 2017 Chicago, USA: 3rd International Urologic Oncology Conference , June 26-28, 2017 Baltimore: 6th World Oral Cancer Congress of the International Academy of Oral Oncology May 17 to 20, 2017, Bangalore, India: Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne: World Congress On Oncology And Its Therapeutic Advances, 4 - 6 September 2017 / Milan, Italy: EMBL-Cancer Core Europe Conference on Cancer Immunotherapy, 2 - 4 Feb 2017, Heidelberg, Germany: 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 24th Asia Pacific Cancer Conference, June 22- 24, 2017, Seoul, Korea: Stem Cells and Cancer Gordon Research Conference, February 12-17, 2017, Lucca (Barga), Italy.

Related Cancer Conferences | Oncology Conferences | Cancer Science Conferences

Track 4: Cancer Causes and Prevention

Disease is consequences of anomalous cell divisions these cells can spread in different parts of bodies. Hereditary Mutation and Heredity there are some growth which might be exchange starting with one part then onto the next in family like bosom malignancy ovarian, colorectal, and prostate disease. Viral and Bacterial Infection there are some infection and microorganisms which is known not the growth. A few microscopic organisms are cancer causing like bacterium H. pylori and its cause in gastric malignancy. Physical and Chemical Agents are changes the hereditary material like DNA of a living beings that can changes the interpretation and translation and DNA replication which can drives cell demise. Hormones and Radiations Androgens are the hormone required for typical development and capacity of the prostate .and its additionally helps in the development of prostate disease. Tumor Vaccines uses to treat the growth the disease might exist malignancy or keeps the advancement malignancy. Nourishment and disease great sustenance is imperative to the tumor patients its offers quality to the general population. Changes in Lifestyle are likewise mindful to increments in the growth rates like smoking drinking no physical action.

Recommended Conferences:

16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE: Global Summit on Oncology & Cancer, May 25-27, 2017  Osaka, Japan: International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE: 9th International Cancer Biomarkers Conference, August 07-09, 2017  Osaka, Japan: 15th World Congress on Cancer Therapy December 05-07, 2016 Philadelphia, Pennsylvania, USA: 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA: Asia Pacific Breast Cancer Summit 17-19 Feb 2017, Hong Kong: 4th Asia Pacific Gastroenterology Cancer Summit , April 28-30, 2017 Singapore: ELCC 2017 European Lung Cancer Conference, May 05- 08 2017, Switzerland: IMPAKT 2017 Breast Cancer Conference 04 - 06 May 2017, Brussels, Belgium European Lung Cancer Conference, May 5-8, 2017, Switzerland;  25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 2nd  Paediatric Oncology Conference , June 22-23, 2017 Philadelphia, USA; Paediatric Neuro-Oncology, Feb 13 2017 London, United Kingdom.

Related Cancer Conferences | Oncology Conferences | Cancer Science Conferences

Track 5: Cancer Diagnosis and Cancer Diagnostics

Analytic testing includes in test and the system to gets the compliance about the disease. There are numerous sorts of tests to conclusion the growth. Biopsy test is most normal test to think about the cancer.in this test little measure of tissue taken to look at the likelihood of disease. There are various sorts of biopsies Needle biopsy, Aspiration biopsy, Prostate biopsy, Liver biopsy, Skin biopsy. Mammography in this test conclusion of bosom ailment occurs. Endoscopy in this test specialist embeds an endoscope through a little cut, or an opening in the body, The Cancer Diagnostics Market includes different parts of treatment. It is fragmented on the premise Technology, Application and Region. In light of Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy, the tumor diagnostics business sector is classified into stage construct and instrument-based with respect to the application, the malignancy diagnostics business sector is sectioned into lung disease, bosom growth, colorectal malignancy, melanoma, and others. On the premise of area, the business sector is separated into North America, Europe, Asia, and Rest of the World (RoW). Rest of the World contains Latin America, Pacific nations, and Middle East and Africa. North America is required to represent the biggest offer in the growth diagnostics market, trailed by Europe and Asia.

Recommended Conferences:

International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany: 19th World Cancer Conference, Nov 21-23, 2017 London, UK: 11th International Conference on Leukaemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain: Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France: 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2017 Atlanta, Georgia, USA: 2nd International Congress on Gynaecologic Oncology, and Contemporary Issues in Women Cancers Sep 5-6, 2017 London, UK: International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA: Paediatric Neuro-Oncology, Feb 13 2017 London, United Kingdom; Paediatric Academic Cancer Society Conference, May 6–9, 2017, California, USA, Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE: European Cancer Congress 27-30 January 2017, Amsterdam: 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 34th Annual Miami Breast Cancer Conference March 9-12, 2017 Miami Beach, FL: BIT's 10th Annual World Cancer Congress 19-21, May 2017, Barcelona, Spain: Iaslc/Esmo European Lung Cancer Conference May 5 - 8 2017, Geneva, Switzerland.

Related Cancer Conferences | Oncology Conferences | Cancer Science Conferences

Track 6: Cancer Treatment and Therapeutics

Growth can be dealt with by various procedures like Radiation Therapy utilizes ionizing radiation to control or execute harmful cells. Radiation treatment is regularly connected to the malignant tumor on account of its capacity to control cell development. Chemotherapy Therapy incorporates hostile to diseases medicates that are given as a feature of institutionalized chemotherapy regimen. Bone Marrow Transplantation is a treatment that happens in the event of leukaemia, lymphoma and myeloma. Hormone Replacement Therapy where in the patient, over the span of restorative treatment, gets hormones, either to supplement an absence of normally happening hormones, or to substitute different hormones for actually happening hormones. Surgery and Laparoscopy depicts the execution of surgical techniques with the help of a camcorder and a few dainty instruments. Amid the surgical system, little cuts of up to a large portion of an inch are made and plastic tubes called ports are set through these entry points. Immunotherapy is a sort of disease treatment that helps invulnerable framework against battle malignancy.

Recommended Conferences:

Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK: 14th Annual Translational Medicine and Oncologists Conference Meet November 28-30, 2016 San Francisco, USA: 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain: 3rd World Gynaecologic Oncology Congress, July 20-21, 2017 Chicago, Illinois, USA: 19th Euro Congress on Cancer Science and Therapy, July 20-22, 2017 Lisbon, Portugal: World Congress on Preventive oncology July 20-21, 2017 Chicago, USA: 3rd International Urologic Oncology Conference , June 26-28, 2017 Baltimore: 6th World Oral Cancer Congress of the International Academy of Oral Oncology May 17 to 20, 2017, Bangalore, India: Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne: World Congress On Oncology And Its Therapeutic Advances, 4 - 6 September 2017 / Milan, Italy: EMBL-Cancer Core Europe Conference on Cancer Immunotherapy, 2 - 4 Feb 2017, Heidelberg, Germany: 24th Asia Pacific Cancer Conference, June 22- 24, 2017, Seoul, Korea: Stem Cells and Cancer Gordon Research Conference, February 12-17, 2017, Lucca (Barga), Italy.25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy

Related Cancer Conferences | Oncology Conferences | Cancer Science Conferences

Track 7: Cancer: Types

There are more than 100 sorts of tumor. Sorts of malignancy are normally named for the organs or tissues where the diseases frame, yet they likewise might be portrayed by the kind of cell that shaped them like Lung cancer and upon there classification based on type of tumor and area it differs like Carcinoma with the epithelial tissues and Melanoma with the Skin.

Head and neck disease is a term used to portray various diverse harmful tumors that create in or around the throat, larynx, nose, sinuses, and mouth. Most head and neck growths are squamous cell carcinomas. This sort of malignancy starts in the level, squamous cells that make up the thin layer of tissue on the surface of the structures in the head and neck. Specifically underneath this coating, which is known as the epithelium, a few regions of the head and neck have a layer of sodden tissue, called the mucosa. On the off chance that a growth is restricted to the squamous layer of cells, it is called carcinoma in situ. In the event that the growth has developed past this layer and moved into the more profound tissue, then it is called intrusive squamous cell carcinoma.

Recommended Conferences:

25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE: Global Summit on Oncology & Cancer, May 25-27, 2017  Osaka, Japan: International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE: 9th International Cancer Biomarkers Conference, August 07-09, 2017  Osaka, Japan: 15th World Congress on Cancer Therapy December 05-07, 2016 Philadelphia, Pennsylvania, USA: 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA: Asia Pacific Breast Cancer Summit 17-19 Feb 2017, Hong Kong: 4th Asia Pacific Gastroenterology Cancer Summit , April 28-30, 2017 Singapore: ELCC 2017 European Lung Cancer Conference, May 05- 08 2017, Switzerland: IMPAKT 2017 Breast Cancer Conference 04 - 06 May 2017, Brussels, Belgium European Lung Cancer Conference, May 5-8, 2017, Switzerland;  2nd  Paediatric Oncology Conference , June 22-23, 2017 Philadelphia, USA; Paediatric Neuro-Oncology, Feb 13 2017 London, United Kingdom.

Related Cancer Conferences | Oncology Conferences | Cancer Science Conferences

Track 8: Cancer Staging

Staging is the process of judgment out how much cancer is in a person’s body and where it’s positioned. It’s how the doctor determines the stage of a person’s cancer. For most types of cancer, doctors use staging info to help plan treatment and to predict a person’s outlook. Although each person’s situation is dissimilar, cancers with the same stage tend to have similar outlooks and are often treated the same way. The cancer phase is also a way for doctors to describe the extent of the cancer when they talk with each other about a person’s cancer.

They are different types of Staging like Clinical Staging, Pathologic Staging and Post Therapy Staging determines how abundant cancer remains after a patient is first treated with systemic and radiation treatment prior to their surgery or where no operation is performed. This can be evaluated by clinical staging guidelines and pathologic staging guidelines.

Recommended Conferences:

International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany: 19th World Cancer Conference, Nov 21-23, 2017 London, UK: 11th International Conference on Leukaemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain: Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France: 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2017 Atlanta, Georgia, USA: 2nd International Congress on Gynaecologic Oncology, and Contemporary Issues in Women Cancers Sep 5-6, 2017 London, UK: International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA: Paediatric Neuro-Oncology, Feb 13 2017 London, United Kingdom; Paediatric Academic Cancer Society Conference, May 6–9, 2017, California, USA, Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE: European Cancer Congress 27-30 January 2017, Amsterdam: 34th Annual Miami Breast Cancer Conference March 9-12, 2017 Miami Beach, FL: BIT's 10th Annual World Cancer Congress 19-21, May 2017, Barcelona, Spain: Iaslc/Esmo European Lung Cancer Conference May 5 - 8 2017, Geneva, Switzerland.

Related Cancer Conferences | Oncology Conferences | Cancer Science Conferences

Track 9: Cancer Biomarkers

A cancer biomarker can be a process substance that indicates the presence of cancer in the body. It may be a molecule secreted by tumor cells or a particular response of the body because of the presence of cancer. Biomarkers may genetic, epigenetic, proteomic, glycaemic, or imaging. They can be used for cancer diagnosis, prognosis, medicine, epidemiology of cancer. Those biomarkers that are particularly associated with mutations offer a quantitative way to determine when individuals are predisposed to particular types of cancers. Mutations of genes like BRCA1 and BRCA2 are advanced breast cancer biomarkers, and mutations on genes like KRAS, p53, EGFR, erbB2 are used for colorectal, oesophageal, liver, and pancreatic cancer.

Recommended Conferences:

Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK: 14th Annual Translational Medicine and Oncologists Conference Meet November 28-30, 2016 San Francisco, USA: 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain: 3rd World Gynaecologic Oncology Congress, July 20-21, 2017 Chicago, Illinois, USA: 19th Euro Congress on Cancer Science and Therapy, July 20-22, 2017 Lisbon, Portugal: World Congress on Preventive oncology July 20-21, 2017 Chicago, USA: 3rd International Urologic Oncology Conference , June 26-28, 2017 Baltimore: 6th World Oral Cancer Congress of the International Academy of Oral Oncology May 17 to 20, 2017, Bangalore, India: Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne: World Congress On Oncology And Its Therapeutic Advances, 4 - 6 September 2017 / Milan, Italy: EMBL-Cancer Core Europe Conference on Cancer Immunotherapy, 2 - 4 Feb 2017, Heidelberg, Germany: 24th Asia Pacific Cancer Conference, June 22- 24, 2017, Seoul, Korea: Stem Cells and Cancer Gordon Research Conference, February 12-17, 2017, Lucca (Barga), Italy.

Track 10: Cancer and Pharmacology

 Tranquilize cooperation’s in oncology are of specific significance attributable to the slender helpful record and the inborn poisonous quality of anticancer specialists. Connections with different medicines can bring about little changes in the pharmacokinetics or pharmacodynamics of a chemotherapy operator that could fundamentally adjust its viability or poisonous quality. Enhancements in vitro strategies and early clinical testing have made the expectation of conceivably clinically critical medication cooperation’s conceivable.

Recommended Conferences:

16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE: Global Summit on Oncology & Cancer, May 25-27, 2017  Osaka, Japan: International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE: 9th International Cancer Biomarkers Conference, August 07-09, 2017  Osaka, Japan: 15th World Congress on Cancer Therapy December 05-07, 2016 Philadelphia, Pennsylvania, USA: 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA: Asia Pacific Breast Cancer Summit 17-19 Feb 2017, Hong Kong: 4th Asia Pacific Gastroenterology Cancer Summit , April 28-30, 2017 Singapore: ELCC 2017 European Lung Cancer Conference, May 05- 08 2017, Switzerland: IMPAKT 2017 Breast Cancer Conference 04 - 06 May 2017, Brussels, Belgium European Lung Cancer Conference, May 5-8, 2017, Switzerland;  2nd  Paediatric Oncology Conference , June 22-23, 2017 Philadelphia, USA; Paediatric Neuro-Oncology, Feb 13 2017 London, United Kingdom.

Related Cancer Conferences | Oncology Conferences | Cancer Science Conferences

Track 11: Gynaecologic Oncology

Oncology Gynaecology is the study about any cancer that begins in a woman's reproductive organs. The five Gynaecology cancers start in the woman's pelvis at different places. Each cancer is unique by its symptoms, signs, risk factors and in their strategies of prevention. All these five different types of Gynaecology Cancers risk increases with the age. When these cancers were diagnosed at their early stages, the treatment will be more efficient. The five major types of cancer affect a woman's reproductive organs are ovarian, uterine, cervical, vulvar, and vaginal cancer. All these as a group are known as Gynaecology cancers.

Recommended Conferences:

International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany: 19th World Cancer Conference, Nov 21-23, 2017 London, UK: 11th International Conference on Leukaemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain: Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France: 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2017 Atlanta, Georgia, USA: 2nd International Congress on Gynaecologic Oncology, and Contemporary Issues in Women Cancers Sep 5-6, 2017 London, UK: International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA: Paediatric Neuro-Oncology, Feb 13 2017 London, United Kingdom; Paediatric Academic Cancer Society Conference, May 6–9, 2017, California, USA, Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE: European Cancer Congress 27-30 January 2017, Amsterdam: 34th Annual Miami Breast Cancer Conference March 9-12, 2017 Miami Beach, FL: BIT's 10th Annual World Cancer Congress 19-21, May 2017, Barcelona, Spain: Iaslc/Esmo European Lung Cancer Conference May 5 - 8 2017, Geneva, Switzerland; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy.

Related Cancer Conferences | Oncology Conferences | Cancer Science Conferences

Track 12: Cancer Prognosis

Cancer prognosis gives us the information about the percentage of people who survive a certain type of cancer for specific amount of time. There are different ways to measure and report survival and different types of cancer survival statistics. Cancer survival rates are supported the research by giving information gathered from about hundreds or thousands of individuals with a particular cancer. Some of the factors that affect prognosis like the type of cancer, its location in the body, the stage, size of the cancer, the cancer’s grade, age of the patients etc. The period of time varies; it may be 1-5 years. Cancer specific survival is also called as disease-specific survival.

Recommended Conferences:

Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK: 14th Annual Translational Medicine and Oncologists Conference Meet November 28-30, 2016 San Francisco, USA: 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain: 3rd World Gynaecologic Oncology Congress, July 20-21, 2017 Chicago, Illinois, USA: 19th Euro Congress on Cancer Science and Therapy, July 20-22, 2017 Lisbon, Portugal: World Congress on Preventive oncology July 20-21, 2017 Chicago, USA: 3rd International Urologic Oncology Conference , June 26-28, 2017 Baltimore: 6th World Oral Cancer Congress of the International Academy of Oral Oncology May 17 to 20, 2017, Bangalore, India: Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne: 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; World Congress On Oncology And Its Therapeutic Advances, 4 - 6 September 2017 / Milan, Italy: EMBL-Cancer Core Europe Conference on Cancer Immunotherapy, 2 - 4 Feb 2017, Heidelberg, Germany: 24th Asia Pacific Cancer Conference, June 22- 24, 2017, Seoul, Korea: Stem Cells and Cancer Gordon Research Conference, February 12-17, 2017, Lucca (Barga), Italy.

Related Cancer Conferences | Oncology Conferences | Cancer Science Conferences

Track 13: Oncology Nursing

An Oncology Nurse offers care for cancer patients and those at risk for getting the disease. They monitor physical conditions, prescribe medication, and manage chemotherapy and other treatments. Oncology is one of the greatest challenging and satisfying fields in nursing and no two days on the job are forever the same.

Recommended Conferences:

16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE: Global Summit on Oncology & Cancer, May 25-27, 2017  Osaka, Japan: International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE: 9th International Cancer Biomarkers Conference, August 07-09, 2017  Osaka, Japan: 15th World Congress on Cancer Therapy December 05-07, 2016 Philadelphia, Pennsylvania, USA: 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA: Asia Pacific Breast Cancer Summit 17-19 Feb 2017, Hong Kong: 4th Asia Pacific Gastroenterology Cancer Summit , April 28-30, 2017 Singapore: 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; ELCC 2017 European Lung Cancer Conference, May 05- 08 2017, Switzerland: IMPAKT 2017 Breast Cancer Conference 04 - 06 May 2017, Brussels, Belgium European Lung Cancer Conference, May 5-8, 2017, Switzerland;  2nd  Paediatric Oncology Conference , June 22-23, 2017 Philadelphia, USA; Paediatric Neuro-Oncology, Feb 13 2017 London, United Kingdom.

Related Cancer Conferences | Oncology Conferences | Cancer Science Conferences

Track 14: Cancer Vaccines

Tumor progression is the third and last phase in tumor growth. This phase is categorized by increased growth speed and invasiveness of the tumor cells. As a result of the evolution, phenotypical changes happen and the tumor develops more aggressive and acquires greater malignant potential. Together with the progression, more and more aneuploidy occurs. 

A cancer vaccine is a vaccine that either treats existing cancer or prevents development of a cancer. Cancer vaccines belong to a class of substances known as biological response modifiers. Biological response modifiers work by stimulating or restoring the immune system’s ability to fight infections and disease. The broad categories include vaccines to prevent cancer; prophylactic vaccines & therapeutic vaccines and vaccines to treat cancer; antigen vaccines, DNA vaccines, whole cell vaccines etc.

The tumor microenvironments the cellular atmosphere popular which the tumor exists, including surrounding blood vessels, immune cells, fibroblasts, bone marrow-derived inflammatory cells, lymphocytes, signalling molecules and the extracellular medium.

Recommended Conferences:

International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany: 19th World Cancer Conference, Nov 21-23, 2017 London, UK: 11th International Conference on Leukaemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain: Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France: 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2017 Atlanta, Georgia, USA: 2nd International Congress on Gynaecologic Oncology, and Contemporary Issues in Women Cancers Sep 5-6, 2017 London, UK: International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA: Paediatric Neuro-Oncology, Feb 13 2017 London, United Kingdom; Paediatric Academic Cancer Society Conference, May 6–9, 2017, California, USA, Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE: European Cancer Congress 27-30 January 2017, Amsterdam: 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 34th Annual Miami Breast Cancer Conference March 9-12, 2017 Miami Beach, FL: BIT's 10th Annual World Cancer Congress 19-21, May 2017, Barcelona, Spain: Iaslc/Esmo European Lung Cancer Conference May 5 - 8 2017, Geneva, Switzerland.

Related Cancer Conferences | Oncology Conferences | Cancer Science Conferences

Track 15: Cancer and Pharmaceutics

The discovery of new cancer drugs happens in a variety of ways like an Accidental discovery in case of the Nitrogen mustard, depends upon the Testing plants, fungi, and animals and reviewing the biology of malignant cells. Maximum scientists who are generating cancer drugs twitch by equating the genetics originated in DNA and cellular processes of cancer cells to healthy cells. These identify imperative phases in the cancer growth procedure that a drug could possibly fix. Once drugs are formed, scientists test them on humanoid tumor cells in the lab to see as they halt the growth of cancer cells. Next, they test the drug in animals to check it is still effective at treating cancer. Researchers test the drug in two or more animal species. Testing in animals helps academics learn how the body uses the new drug. Also, it shows what side effects the drug may cause and what dose of the drug to use in human research trials.

Recommended Conferences:

Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK: 14th Annual Translational Medicine and Oncologists Conference Meet November 28-30, 2016 San Francisco, USA: 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain: 3rd World Gynaecologic Oncology Congress, July 20-21, 2017 Chicago, Illinois, USA: 19th Euro Congress on Cancer Science and Therapy, July 20-22, 2017 Lisbon, Portugal: World Congress on Preventive oncology July 20-21, 2017 Chicago, USA: 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 3rd International Urologic Oncology Conference , June 26-28, 2017 Baltimore: 6th World Oral Cancer Congress of the International Academy of Oral Oncology May 17 to 20, 2017, Bangalore, India: Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne: World Congress On Oncology And Its Therapeutic Advances, 4 - 6 September 2017 / Milan, Italy: EMBL-Cancer Core Europe Conference on Cancer Immunotherapy, 2 - 4 Feb 2017, Heidelberg, Germany: 24th Asia Pacific Cancer Conference, June 22- 24, 2017, Seoul, Korea: Stem Cells and Cancer Gordon Research Conference, February 12-17, 2017, Lucca (Barga), Italy.

Related Cancer Conferences | Oncology Conferences | Cancer Science Conferences

Track 16: Cancer Genomics and Metabolomics

Oncogenomics is a sub field of genomics that characterises cancer related genes. It focuses on genomic, epigenomic and transcript modifications in cancer. Cancer is a genetic disease caused by congregation of DNA mutations and epigenetic alterations leading to uncontrolled cell proliferation and neoplasm development. The goal of oncogenomics is to identify new oncogenes or tumor suppressor genes that may provide new visions into cancer diagnosis, expecting clinical result of growths and new targets for cancer therapies.

Recommended Conferences:

16th Global Annual Oncologists Meeting, April 24-25, 2017 Dubai, UAE: Global Summit on Oncology & Cancer, May 25-27, 2017  Osaka, Japan: International Conference on Cancer Diagnostics, November 27- 28, 2017  Dubai, UAE: 9th International Cancer Biomarkers Conference, August 07-09, 2017  Osaka, Japan: 15th World Congress on Cancer Therapy December 05-07, 2016 Philadelphia, Pennsylvania, USA: 8th International Clinical Research and Biomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA: 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; Asia Pacific Breast Cancer Summit 17-19 Feb 2017, Hong Kong: 4th Asia Pacific Gastroenterology Cancer Summit , April 28-30, 2017 Singapore: ELCC 2017 European Lung Cancer Conference, May 05- 08 2017, Switzerland: IMPAKT 2017 Breast Cancer Conference 04 - 06 May 2017, Brussels, Belgium European Lung Cancer Conference, May 5-8, 2017, Switzerland;  2nd  Paediatric Oncology Conference , June 22-23, 2017 Philadelphia, USA; Paediatric Neuro-Oncology, Feb 13 2017 London, United Kingdom.

Related Cancer Conferences | Oncology Conferences | Cancer Science Conferences

Track 17: Complementary and Alternative Medicine

There are some alternative medicines to healing cancer.  Ayurveda gives the different levels of support to the patients like emotional and spiritual. Herbals can be applied over the tumour which gives deep healing to patients. Yoga can help centre thoughts and maintain flexibility, but it also beneficial to the people living with cancer. Symptoms of fatigue, insomnia, and pain can all lower your quality of life with cancer. Homeopathic medicine  made from plant, mineral and animal substances. Aromatherapy is use of oils these oils are the taken from the flowers, fruit, seeds, leaves, root or bark of certain plants. There are different theories to explain how aromatherapy might work. One is directly absorb the oils through the skin into body tissues. The second theory relates to sense of smells. Naturopathic medicine is a system of healing that focuses on supporting and stimulating the body’s ability to heal it. Naturopathy is the medicine supporting the people to get healing by it.

Recommended Conferences:

International Conference on Epigenetics 2017, November 13-15, 2017 Frankfurt, Germany: 19th World Cancer Conference, Nov 21-23, 2017 London, UK: 11th International Conference on Leukaemia and Hematologic Oncology December 04-05, 2017 Madrid, Spain: Medical Expo Congress on Cancer Drugs and Therapeutics, Sep 11-13, 2017 Paris, France: 2nd International Conference on Antimicrobial Agents and Chemotherapy, October 19-20, 2017 Atlanta, Georgia, USA:25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; 2nd International Congress on Gynaecologic Oncology, and Contemporary Issues in Women Cancers Sep 5-6, 2017 London, UK: International Conference on Gastrointestinal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA: Paediatric Neuro-Oncology, Feb 13 2017 London, United Kingdom; Paediatric Academic Cancer Society Conference, May 6–9, 2017, California, USA, Cancer Global Conferences Middle East November 21-23, 2016 Dubai, UAE: European Cancer Congress 27-30 January 2017, Amsterdam: 34th Annual Miami Breast Cancer Conference March 9-12, 2017 Miami Beach, FL: BIT's 10th Annual World Cancer Congress 19-21, May 2017, Barcelona, Spain: Iaslc/Esmo European Lung Cancer Conference May 5 - 8 2017, Geneva, Switzerland.

Related Cancer Conferences | Oncology Conferences | Cancer Science Conferences

Track 18: Oncology Case Reports

Globally it is expected that there are 7.6 million new cancer cases per annum, out of which 52% happen in developing countries. Cancer case reports should include relevant positive and negative findings from history, examination and investigation, and can include clinical photographs; provided these are accompanied by written consent to publish from the patients. Case reports should include an up-to-date review of all previous cases in the field.

Recommended Conferences:

Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK: 14th Annual Translational Medicine and Oncologists Conference Meet November 28-30, 2016 San Francisco, USA: 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain: 3rd World Gynaecologic Oncology Congress, July 20-21, 2017 Chicago, Illinois, USA: 19th Euro Congress on Cancer Science and Therapy, July 20-22, 2017 Lisbon, Portugal: World Congress on Preventive oncology July 20-21, 2017 Chicago, USA: 3rd International Urologic Oncology Conference , June 26-28, 2017 Baltimore: 6th World Oral Cancer Congress of the International Academy of Oral Oncology May 17 to 20, 2017, Bangalore, India: Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne:25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; World Congress On Oncology And Its Therapeutic Advances, 4 - 6 September 2017 / Milan, Italy: EMBL-Cancer Core Europe Conference on Cancer Immunotherapy, 2 - 4 Feb 2017, Heidelberg, Germany: 24th Asia Pacific Cancer Conference, June 22- 24, 2017, Seoul, Korea: Stem Cells and Cancer Gordon Research Conference, February 12-17, 2017, Lucca (Barga), Italy.

Related Cancer Conferences | Oncology Conferences | Cancer Science Conferences

About Conference

Conferenceseries LLC invites all the participants across the globe to attend the "Global Summit on Oncology & Cancer” slated on May 25-27, 2017 Osaka, Japan.

Theme: To Say Cancer is a Challenge but Not an End

Global Cancer 2017 directs towards addressing main issues as well as future strategies of Cancer. This is going to be the largest and most promising international conference where the program includes Clinical Oncologists, Registered Nurses, Nurse practitioners and the entire medical team involved in patient care, researchers, professional, early career individuals and patient advocates who wish to learn principles of tumour immunology and immunotherapy well as decision makers will come to discuss and debate on various aspects of the challenges, risks and investment opportunities throughout the complete information of Cancers. Global Cancer Meeting at Osaka, Japan will deal with Prevention, Diagnosis, and Treatment diseases of the Organ-related Cancers and its innovative techniques. Global Cancer 2017  will also provide the three days of discussions on methods and strategies related to management and quality improvement of Cancer and as well as to explore the new ideas and concepts on global scale and the topics include lung cancer, breast cancer, bone cancer, leukaemia, blood cancer, cervical cancer, colon-rectum cancer, paediatric cancer, surgical cancer, Prostate cancer, thyroid cancer.

  • This year about 564,800 Americans are expected to die of cancer more than 1,500 people a day. Cancer is the second leading cause of death in the US. One of every four deaths in the US is from cancer. Since 1990, there have been approximately 5 million cancer deaths.
  • Lung Cancer, Blood Cancer, Breast Cancer are most common Cancers in Japan.

According to 2012 statistics roughly 14.1 million cases are conveyed and 8.2 million deaths are reported. Lung, Liver, Stomach and bowel cancers cause the most common deaths among the worldwide that accounts nearly half of all the cancer deaths. About 70% increases in the cases are to be expected over the next 2 decades. In males 5 most common sites of cancer are detected in 2012 were lung, prostate, colorectal and liver cancers. In women 5 most shared sites diagnosed were breast, lung and stomach cancer. Nearly 60% of the globe overall new cases arise in the Africa, Asia, Central and America areas. All over the world Denmark ranks 1st in the cancer deaths USA is accompanied next to it. 

Conference Series LLC  which is comprised of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+Workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is organizing conferences all over the globe. Conferenceseries LLC hosts numerous Cancer Conferences, Cancer meeting, global cancer conference, European Oncology Conferences, Surgical oncology like skin cancer conference, breast cancer conference, liver cancer conference, lung cancer meetings, and Oncology Conferences where knowledge transfer takes place through debates, round table discussions, poster presentations, workshops, symposia and exhibitions and which helps get possibilities for treating the diseases with new era, technology and research.

Why to attend?

With members from around the world focused on learning about Oncology & Cancer; this is your best opportunity to reach the largest assemblage of participants from the Oncology & Cancer community, oncology society, European Oncology Conferences. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this three day event. World renowned speakers, the most recent techniques, developments, and the newest updates in Oncology are hallmarks of this conference.

Target Audience:

  • Oncologists
  • Radiologists
  • Pathologists
  • Haematologists
  • Academicians
  • Research Scholars
  • Students
  • Oncology Associations & Societies
  • Business Entrepreneurs
  • Software Developing Companies
  • Medical Devices Companies
  • Biomedical Companies
  • Biotechnology Companies
  • Data Management Companies

Market Analysis

Cancer is a generic term for a large group of diseases that can affect any part of the body. Other terms used are malignant tumors and neoplasms. Metastases are the major cause of death from cancer. Cancer is a leading cause of death worldwide, accounting for 8.2 million deaths in 2012. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the globe. We invite you to join us at the Global Summit on Oncology & Cancer, where you will be sure to have a meaningful experience with scholars from around the world.

Importance and Scope

Global Cancer 2017 will be the best platform for all the scientist, radiologists, oncologists, research scholars, students who are working in this field to exchange their knowledge related to Cancer and oncology. This international event is an effort to find an alternative for invasive imaging technique against cancer like Lung Cancer, Liver Cancer, Breast Cancer, Kidney Cancer, Cancer in adults & cancer in children.

North America is the leading regional marketplace for cancer diagnostics with a part of approximately 40.7% of the general cancer diagnostics market in terms of income in 2013, shadowed by Europe which accounted for around 29.1% share in the market.

Why Osaka??

Global Summit on Oncology & Cancer is going to be held in Osaka, Japan. Osaka is the second largest metropolitan area in Japan and serves a major economic hub. Historically a merchant city, Osaka is named as the “Nation’s Kitchen”. With a individuals of 2.5 million, Osaka is Japan’s third largest and second most important city. It has been the financial capital of the Kansai area for many eras. The metropolis’s west side has the chief port as well as a tourist destination with attractions such as Kyocera Dome, Universal Studios Japan, Osaka aquarium, Osaka castle, Umeda sky construction and the Tempozan Harbour Township. The Museum of Oriental Ceramics holds more than 2,000 pieces of ceramics, from China, Korea, Japan and Vietnam, featuring displays of some of their Korean celadon under natural light.

Major Medical Universities

Worldwide

  • Harvard University
  • University of Minnesota
  • Mayo Medical School
  • Pittsburgh School of Medicine
  • Yale University
  • University of Cambridge
  • University of Oxford Stanford University
  • Yale University
  • Emory University
  • John Hopkins University
  • Kings College London
  • Feinberg School of Medicine
  • University of Wisconsin
  • UNC School of Medicine
  • Karolinska University

In Asia Pacific

  • The University of Tokyo
  • National University of Singapore (NUS)
  • Kyoto University
  • University of Hong Kong (HKU)
  • Peking University
  • Seoul National University (SNU)
  • National Taiwan University (NTU)
  • Osaka University
  • Tsinghua University0
  • The Chinese University of Hong Kong (CUHK)
  • Fudan University
  • The Hong Kong University of Science and Technology (HKUST)
  • Taipei Medical University
  • Mahidol University
  • KAIST - Korea Advanced Institute of Science and Technology
  • Yonsei University
  • Shanghai Jiao Tong University
  • Nanyang Technological University (NTU)
  • Chulalongkorn University
  • Tohoku University
  • Tokyo Medical and Dental University
  • Kyushu University
  • Nagoya University
  • Hokkaido University
  • Sungkyunkwan University
  • University of Science and Technology of China
  • Pohang University of Science and Technology (POSTECH)
  • Korea University
  • Universiti Malaya (UM)
  • Zhejiang University
  • Keio University
  • Indian Institute of Science
  • Tokyo Institute of Technology
  • Universiti Kebangsaan Malaysia (UKM)
  • Universiti Sains Malaysia (USM)
  • Beijing University of Chinese Medicine
  • National Tsing Hua University
  • Nanjing University
  • Kyung Hee University
  • National Yang Ming University
  • University of Indonesia
  • University of the Philippines
  • University of Tsukuba
  • Bandung Institute of Technology (ITB)
  • Hanyang University
  • Indian Institute of Technology Bombay (IITB)
  • National Cheng Kung University
  • Universiti Putra Malaysia (UPM)
  • Beijing Institute of Technology
  • University of Delhi

Major Cancer Associations:

Worldwide

  • American Association for Cancer Research
  • Virginia Cancer Institute
  • American Brain Tumor Association
  • American Society of Pediatric Hematology/Oncology
  • Association of Cancer Physicians
  • American Childhood Cancer Organization
  • American Society of Clinical Oncology
  • Australasian Lung Cancer Trials Group
  • International Cancer Research Partnership (ICRP)
  • American Association for Cancer Research (AACR)
  • American Society of Clinical Oncology (ASCO)
  • International Agency for Research on Cancer (IARC)
  • Cancer Society of New Zealand
  • Irish Cancer Society
  • Australian Cervical Cancer Foundation
  • Medical Centre Cologne
  • Cancer Research UK
  • Australian Prostate Cancer Research
  • Peter McCollum Cancer Centre
  • The European Cancer Organization (ECCO)
  • German Cancer Research Centre

In Asia Pacific

  • The Asia-Pacific Urogynecology Association
  • The Asia-Pacific Cancer Society Training
  • Asian Cancer Foundation India
  • The Max Foundation
  • Childhood Cancer International Netherlands
  • The Asia Pacific Prostate Society

Top Centres and Hospitals in Japan

  • Medical Excellence JAPAN
  • Japan Community Health care Organization Chukyo Hospital
  • Aichi Cancer Center Hospital
  • Japanese Red Cross Nagoya Daiichi Hospital
  • Kyoto University Hospital
  • Dokkyo Medical University Hospital
  • Japan Hospital Association
  • Aizawa Hospital
  • University Hospital Kumamoto University
  • International Medical Center of Japan

Market Analysis Report

There are recent advancements in the cancer treatments & cancer care is quickening. A cluster of innovative treatments, often mutual with other new or existing medicines, and regularly related with biomarkers, are emergent from the research and development pipeline. Over the past five years, 70 new oncology treatments have been launched and are being used to treat over 20 different tumour types.

The worldwide cancer immunotherapies revenue reached $30.8 billion in 2012. This market is expected to grow to nearly $34.3 billion in 2013 and $67.9 billion in 2018 with a multiple annual growth rate (CAGR) of 14.7% over the five-year period, 2013 to 2018. This report   comprises conversation of the regulatory atmosphere, current and emerging technologies, cancer occurrence, market predictions and market share, lengthwise with latest trends and clinical trials.

Major Cancer-Pharma Companies:

The total cost of cancer therapeutics and medicines used in supportive care– measured at the ex-manufacturer price level before the application of rebates or other price concessions – reached $107 billion in 2015, representing an increase in constant dollars of 11.5% over the prior year

Annual global growth in the oncology drug market is expected to be 7.5 – 10.5 % through 2020, reaching $150 billion. Wider utilization of new products—especially immunotherapies—will drive much of the growth, offset by reduced use of some existing treatments with inferior clinical outcomes.

The global market for biologic cancer treatment totalled about $51.2 billion in 2014 and is expected to reach $66.4 billion in 2019, registering a compound annual growth rate (CAGR) of 5.4% for the period 2014-2019. It includes current issues and trends affecting the industry, costs and factors influencing demand. The report covers biological products in development, biological products in clinical trials, and currently marketed and late-stage development biologic cancer products.

Past Conference Report

World Cancer 2016

 

We extend a heartily thanks to all of our wonderful speakers, conference attendees as the World Cancer 2016 Conference was a great success!!

Conferenceseries LLC hosted the “12th World Cancer Conference” during September 26-28, 2016 at Hilton Heathrow Airport Hotel, London, UK. The conference was focused on Cancer & Oncology studies with the theme “Integrating every bit of cancer research: Prevention, diagnosis and cure”. Generous response and active participation was received from scientists, researchers and leaders from Pharma, government organizations, students who made this conference as one of most successful and productive events in 2016 from Cancer & Oncology Conferences

The conference was initiated with Opening Ceremony followed by with a series of lectures delivered by both Honourable Guests and members of the Keynote forum.

The list included:

·         Alvaro Macieira-Coelho, French Institute of Health and Medical Research, France

·         Liane Deligdisch, Mount Sinai School of Medicine, USA

·         Katharina Pachmann, SIMFO GmbH Bayreuth, Germany

·         Ella L Kim, Johannes Gutenberg University Medical Centre, Germany

·         Qingyong Ma, Xi’an Jiaotong University, China

·         Sabine Mai, University of Manitoba, Canada

·         Nichola C Garbett, University of Louisville School of Medicine, USA

·         Alain Charest, Harvard Medical School, USA

We heartily acknowledge the conference moderator Dr. Jessie for her support for the conference. We are also gratified to various outside experts, company representatives and other renowned personalities who supported the conference by facilitating the discussion forums. Our sincere thanks to Organizing Committee Members for their gracious presence, support and assistance towards World Cancer 2016

Trailing the success of World Cancer 2016, Conferenceseries LLC would like to announce the initiation of the “19th World Cancer Conference” to be held during November 21-23, 2017 at London, UK.

For More details: http://cancer.global-summit.com/europe/


Past Reports  Proceedings  Gallery  

Cancer Science-2015

 

Thanks to all our admirable speakers, conference attendees contributed to the success of 5th World Congress on Cancer Therapy organized by Conferenceseries LLC during September 28-30, 2015 Atlanta, Georgia, USA with the theme Innovations and Novel Approaches in Diagnosis and Treatment of different Cancers which was a great success where eminent keynote speakers from various reputed universities, institutions and hospitals with their splendid presence addressed the gathering.

Conferenceseries LLC would like to convey a warm gratitude to all Honorable Guests and Keynote Speakers of Cancer Therapy-2015:

Jack C. Westman, University of Wisconsin School of Medicine, USA
Erwin G. Van Meir, Winship Cancer Institute, USA
Yoshiaki Omura, New York Medical College, USA
Michael Weber, Weber Medical, Germany
Anupam Bishayee, Larkin Health Sciences Institute College of Pharmacy, USA

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote-presentations:

A review of cancer immunotherapies and nutritional therapies: Jack C. Westman, University of Wisconsin School of Medicine & Public Health, USA BAI1 is a brain-specific tumor suppressor: Erwin G. Van Meir, Winship Cancer Institute, Emory University, USA

New simple method of detecting various cancers & their biochemical information from rapidly changing part of QRS complex of ECGs and its clinical application for screening and evaluation of cancer: Yoshiaki Omura, New York Medical College, USA

Systemic and interstitial photodynamic laser therapy: New options in oncology: Michael Weber, Weber Medical, Germany

Chemoprevention of experimental mammary carcinoma by Trianthe ma portulacastrum Linn., an Indian dietary and medicinal plant: Anupam Bishayee, Larkin Health Sciences Institute College of Pharmacy, USA

The meeting was executed through various sessions, in which the discussions were held on the following major scientific tracks:

Cancer Cell Biology, Diagnosis and Applied Research

• Organ-Specific Cancer
• Advances in malignancy counteractive action and screening
• Anti-cancer drugs and delivery
• Novel Approaches to Cancer Therapeutics
• Cancer Therapy and Clinical Cancer Research
• Chemotherapy
• Cancer and Lifestyle Connection
• Complementary and Alternative Medicine (CAM)
• Cancer Biomarkers
• Cancer Vaccines
• Cancer Nanotechnology
• Global Cancer Epidemiology
• Cancer Pharmacology
• Cancer Stem Cell Therapy
• Cancer Chemotherapy
• Pediatric Oncology
• Clinical Oncology
• Gastrointestinal Cancer
• Gynecological Cancer
• Radiation Oncology
• Surgical Oncology
• Tumor Virology
• Anti-cancer Agents in Medicinal Chemistry
• Cellular Pathology
• Cancer Metabolomics
• Tumor immunology & immunotherapy

Cancer Therapy 2015 Organizing Committee would like to thank the Moderator of the conference, Sherri Z. Millis from Advanced Individual Medicine, LLC USA who contributed a lot to the smooth functioning of this event.

Conferenceseries LLC, on behalf of the Cancer Therapy 2015, congratulates the best poster awardee, Sitelbanat Yassin, China Pharmaceutical University, Chinafor her outstanding performance and appreciates all the participants who put their research at poster presentations and sincerely wish them every success in their future endeavors. Also, we would like to thank the poster evaluation committee member Amy McCullough from American Humane Association, USA for his valuable support and advice.

Conferenceseries LLC is honored to felicitate Cancer Therapy 2015 Organizing Committee and Editorial Board Members of Journal of Cancer Science & Therapy, Journal of Carcinogenesis & Mutagenesis and Journal of Chemotherapy, Keynote Speakers, Chairs & Co-Chairs and also the Moderator of the conference whose support and efforts made the conference to move in the path of success.


Past Reports  Proceedings  Gallery  

Cancer Science-2014

 

Conferenceseries LLC 4th World Congress on Cancer Science & Therapy was held during October 20-22, 2014 at DoubleTree by Hilton Hotel Chicago - North Shore Conference Center, Chicago, USA.

Generous response and active participation was received from the Editorial Board Members of Conferenceseries LLC Journals, scientists, researchers, as well as experts in the cancer research, leaders from the fields of Cancer Therapy, and students from diverse groups, who made this conference one of the most successful and productive events in 2014 from Conferenceseries LLC.

The conference proceedings were carried out through effectual keynote lectures by:

Dr. Peter Weightman, University of Liverpool, UK
Dr. Sudhakar Akul YakkantiSRI International, USA
Dr. Jeffrey B. Ulmer, Novartis Vaccines & Diagnostics, USA
Dr. Reza Hakkak, University of Arkansas for Medical Sciences, USA

This annual conference brought together eminent experts from different countries in which many modern issues were discussed in depth to provide up-to-date information to the world. On the other hand, the meeting provided a good platform to share their ideas and experiences in the field of cancer therapy.

The conference was greeted by the welcome message by our moderators Juan Jose Marugan, National Institutes of Health, USA and Bernard Friedenson, University of Illinois, USA, and welcomed Honorable guests Sudhakar Akul Yakkanti, SRI International, USA,Anupam Bishayee, California Northstate University, USA, and Reza HakkakUniversity of Arkansas for Medical Sciences, USA.

We sincerely acknowledge all the organizing committee members, moderators, chair and co-chairs, editorial board members, speakers, delegates for their gracious presence, and support in making this event successful. Conferenceseries LLC has taken the privilege of felicitating Cancer Science-2014 Organizing Committee Members, Editorial Board Members and Keynote Speakers who supported for the success of this event. Conferenceseries LLC, on behalf of the conference exhibitors congratulates the Best Poster awardees for their outstanding performance in the field of Cancer Science & Therapy and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Cancer Science-2014. We are glad to inform that all accepted abstracts for the conference have been indexed in Conferenceseries LLC Journal of Cancer Science & Therapy andJournal of Carcinogenesis & Mutagenesis as a special issue. Basing on the conference theme, "Enhanced diagnosis, treatment and management of different cancers”, the speakers recommended organizing the conference in the field of Cancer Science and Therapy in the coming years also.

We are obliged to various experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance towards the success of Cancer Science-2014. 


Past Reports  Gallery  

Cancer Science-2013

 

The 3rd World Congress on Cancer Science & Therapy was organized by Conferenceseries LLC Inc., during October 21-23, 2013 at Double Tree by Hilton Hotel San Francisco Airport, USA. Active participation and generous response was received from the Organizing Committee Members, Editorial Board Members of Conferenceseries LLC Journals, scientists, researchers, as well as experts in the cancer research, Non-government organizations, and students from diverse groups who made this conference as one of the most successful and productive events in 2013 from Conferenceseries LLC.

The conference was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who have driven this event into the path of success.

The conference was initiated with a warm welcome note from Honorable guests. The proceedings went through interactive sessions and panel discussions headed by Jimmy T. Efird, Brody School of Medicine, USA; honorable Moderator for the conference.

The conference proceedings were carried out through various Keynote-presentations by:

  • Dr. Stewart SellWadsworth Center, USA
  • Dr. Michael Retsky, Harvard School of Public Health, USA
  • Dr. Jimmy T. Efird, Brody School of Medicine, USA
  • Dr. Sudhakar Akul YakkantiSRI International, USA
  • Dr. Sherry A. BradfordBuffalo School of Medical and Biomedical Sciences, USA

Also, the conference proceeding was encouraged through the wonderful workshop session on “ Animal Models of Cancer Therapy” organized by Dr. Dorothee HerlynThe Wistar Institute, USA

Conferenceseries LLC has taken the privilege of felicitating Cancer Science-2013 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event. Conferenceseries LLC, on behalf of the conference exhibitors congratulates the Best Poster awardees for their outstanding performance in the field of Cancer Science & Therapy and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Cancer Science-2013. We are glad to inform that all accepted abstracts for the conference have been indexed in Conferenceseries LLC Journal of Cancer Science & Therapy andJournal of Carcinogenesis & Mutagenesis as a special issue. Basing on the conference theme, "Innovations and Novel Therapeutic Strategies in Cancer Science speakers recommended organizing the conference in the field of Cancer Science and Therapy also in the next year.

We are also obliged to various experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance towards the success of Cancer Science-2013.


Past Reports  Gallery  

Cancer Science-2012

 

Conferenceseries LLC’s 2nd World Congress on Cancer Science & Therapy was held during September 10-12, 2012 at Hilton San Antonio Airport, San Antonio, USA.
Generous response and active participation were received from the Editorial Board Members of Conferenceseries LLC Journals, scientists, researchers, as well as experts in the cancer research, leaders from the fields of Cancer Therapy, and students from diverse groups, who made this conference one of the most successful and productive events in 2012 from Conferenceseries LLC.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

  • Cancer Cell Biology
    Diagnostic and Prognostic Cancer Biomarkers
    Advances in Cancer Detection and Imaging
    Cancer: Management & Prevention
    Cancer Therapy
    Clinical Cancer Research
    Carcinogenesis and Mutagenesis
    Conferenceseries LLC in Cancer Research
    Organ-Specific Cancers
    Cancer Genetics

    The conference proceedings were carried out through effectual keynote lectures by:

  • DrSudhakar Akul Yakkanti, Boys Town National Research Hospital, USA
    Dr. Alexei G. Basnakian, University of Arkansas for Medical Sciences, USA
    Dr. Dan Dixon, University of South Carolina, USA
    Dr. Sophia Ran, Southern Illinois University School of Medicine, USA
    Dr. Homer S Black, Baylor College of Medicine, USA


We sincerely acknowledge all the organizing committee members, moderators, chair and co-chairs, editorial board members, speakers, delegates for their gracious presence, and support in making this event successful. Conferenceseries LLC has taken the privilege of felicitating Cancer Science-2012 Organizing Committee Members, Editorial Board Members and Keynote Speakers who supported for the success of this event. Conferenceseries LLC, on behalf of the conference exhibitors congratulates the Best Poster awardees for their outstanding performance in the field of Cancer Science & Therapy and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.

The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Cancer Science-2012. We are glad to inform that all accepted abstracts for the conference have been indexed in Conferenceseries LLC Journal of Cancer Science & Therapy andJournal of Carcinogenesis & Mutagenesis as a special issue.

We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance towards the success of Cancer Science-2012. With the unique feedback from the conference, Conferenceseries LLC would like to announce its "3rd World Congress on Cancer Science & Therapy" to be held during October 21-23, 2013 San Francisco, USA.


Past Reports  Gallery  

Cancer Science-2011

 

The International Conference and Exhibition on Cancer Science and Therapy (Cancer Science-2011), hosted by the Conferenceseries LLC was held on August 15-17, 2011 in Las Vegas, USA. It attracted around 350 delegates from across the cancer science community of the world for a day of lively discussion and debate. The conference focused on the Novel approaches in cancer science & therapy

The conference provided a forum for Medical Specialists, Clinicians, Researchers and Professors, making it largest and most successful international congregation ever assembled by Conferenceseries LLC., It also helped researchers to discuss cancer policy and services, and to make recommendations for the future. 

Cancer Science-2011 speakers discussed on the following topics: 

  • Cancer Cell Biology
  • Cancer Therapies
  • Cancer Biomarkers
  • Clinical Cancer Research
  • Tumor Virology & Pathology
  • Carcinogenesis & Mutagenesis
  • Cancer Detection and Imaging
  • Oncogenomics & Oncoproteomics
  • Cancer Management & Prevention
  • Organ-Specific Cancers
  • Cancer Genetics

We are particularly grateful to our conference chairs and Key note speakers

Dr. Mahin Khatami, National Cancer Institute, USA
Dr. Michael MIngzhao Xing, Johns Hopkins University School of Medicine, USA
Dr. Francois Vallete, INSERM and Universite de Nantes, France
Dr. Stephen Wang, Millennium Pharmaceuticals Inc, USA
Dr. Jimmy Efird, Brody School of Medicine, USA
Dr. John Thompson, University of Waterloo, Canada. 

We are also grateful to other speakers and Senesco Technologies Inc., USA who supported the conference by facilitating the discussion forums. As part of a collaborative effort, Journal of Cancer Science & Therapy and Journal of Carcinogenesis & Mutagenesis has published all papers presented at this meeting as a special issue.

A number of recommendations were made (Key Recommendations)

  • New discoveries in cancer research and its subsequent analysis
  • Topics discussed were driven by research on Biomarkers in Diagnostic & early detection of cancers. Focus on Anti cancer drugs, Chemotherapy and its effects were key highlights of the conference.
  • OMICS in cancer research & ways to prevent and counter cancer was discussed in this session.

Cancer science 2011 witnessed a success in great magnitude. Cancer Science-2012 is also confident of delivering the same success & worldwide participation as in this conference. We would like to thank the members of the steering group- our organizing committee for providing advice on the agenda, and in supporting the conference. We are grateful to our sponsors for their generous sponsorship of the event. 


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date May 25-27, 2017

Speaker Opportunity

Supported By

Journal of Cancer Science & Therapy Journal of Integrative Oncology Journal of Carcinogenesis & Mutagenesis

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner